Abstract
IntroductionRenal transplant subjects are considered at risk for the development of obesity and changes in lipid and glucose metabolism because of the use of immunosuppressive medications.This study was aimed at assessing the prevalence of metabolic syndrome in renal transplant recipients and to identify factors associated with its occurrence. Materials and methodsA cross-sectional study was conducted recruiting renal transplant patients. The metabolic syndrome (MS) was diagnosed according to the criteria of the 2004 revision of ATP III criteria. ResultsMS was found in 43/132 (32.5%) of participants. Also, it was found in 18/70 (25.7%) of males, which was significantly lesser than that found in female 25/62 (40.3%) (p<0.05). hypertension is the commonest criteria of MS as it was found in 31/43 (72%) of the recruited sample. ConclusionsMS is common in the recruited sample here in Iraq. Preventive measures should be taken to prevent such an issue and its related complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
